OmniAb, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for OABI, updated each market day.
OABI AI Sentiment
AI sees no strong directional signal for OmniAb, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About OmniAb, Inc. Common Stock
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Sector
Exchange
Market Cap
$645,533,367
Cap Tier
Employees
89
Headquarters
EMERYVILLE, CA
Listed Since
Nov. 1, 2022
Website
OABI Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OABI Volatility
OmniAb, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
